SCHEMBL22701

SCHEMBL22701

CC(CC(C(=O)O)(C(C)C(=O)O)P(=O)(O)O)C(=O)O

nearest known ligand 0.41

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
FDPS P14324 1/20 0.34
GABRR1 P24046 2/20 0.33
CYP1A2 P05177 1/20 0.33
GRM3 Q14832 2/20 0.32
LAP3 P28838 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11338517 0.83 FDPS (0.33) FDPSGRM3
SCHEMBL6824797 0.78 GRM3 (0.37) GRM3
SCHEMBL11342329 0.78 CHRM1 (0.47) FDPSGRM3
SCHEMBL11334407 0.76 METAP1 (0.39) FDPSGRM3
SCHEMBL11331405 0.76 GRM3 (0.43) CYP1A2GRM3
SCHEMBL11334476 0.76 GRM4 (0.39)
SCHEMBL10360955 0.72 FDPS (0.41) FDPSGABRR1CYP1A2LAP3
SCHEMBL18985288 0.72 FDPS (0.36) FDPSGRM3LAP3
SCHEMBL8635672 0.70 CYP1A2 (0.35) FDPSGABRR1CYP1A2
SCHEMBL8528026 0.70 FOLH1 (0.40) FDPS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4204381-B1 SET CONTROL COMPOSITION FOR CEMENTITIOUS SYSTEMS CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) 2026-05-06 EP disclosed
US-12595209-B2 Mixture comprising glyoxylic acid or condensation or addition products thereof BASF SE (DE) 2026-04-07 US disclosed
US-12534405-B2 Shotcrete composition CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) 2026-01-27 US disclosed
US-12415752-B2 Construction composition CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) 2025-09-16 US disclosed
US-20250276938-A1 DRY MORTAR COMPOSITION CONTAINING METAL SALT OF A POLYOL BASF SE (DE) 2025-09-04 US disclosed
EP-4522577-A1 DRY MORTAR COMPOSITION CONTAINING METAL SALT OF A POLYOL BASF SE (DE) 2025-03-19 EP disclosed
CN-119173489-A Dry mortar composition containing metal salts of polyols 巴斯夫欧洲公司 2024-12-20 CN disclosed
US-20240174568-A1 CEMENTITIOUS COMPOSITION BASF SE (DE) 2024-05-30 US disclosed
US-11981606-B2 Cement-reduced construction composition CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) 2024-05-14 US disclosed
EP-4204382-B1 LIMESTONE CALCINED CLAY CEMENT (LC3) CONSTRUCTION COMPOSITION CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) 2024-03-27 EP disclosed
EP-2609055-B1 ACCELERATOR SIKA TECHNOLOGY AG (CH) 2015-06-24 EP disclosed
US-8608847-B2 Accelerator for hydraulic binders SIKA TECHNOLOGY AG (CH) 2013-12-17 US disclosed
EP-2609055-A1 ACCELERATOR Sika Technology AG (CH) 2013-07-03 EP disclosed
US-20130112116-A1 ACCELERATOR FOR HYDRAULIC BINDERS SIKA TECHNOLOGY AG (CH) 2013-05-09 US disclosed
WO-2012025567-A1 ACCELERATOR SIKA TECHNOLOGY AG (CH) 2012-03-01 WO disclosed
EP-2423175-A1 Accelerator for hydraulic binders Sika Technology AG (CH) 2012-02-29 EP disclosed
US-4252857-A Flameproofing substrate BAYER AKTIENGESELLSCHAFT (DE) 1981-02-24 US disclosed
US-4133872-A Compositions for preparation of aqueous solutions of salts of lower valence 99 technetium HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KGAA) (DE) 1979-01-09 US disclosed
US-4086334-A A CALCITONIN AND AN ADJUVANT CONTAINING CARBOXY AND/OR PHOSPHONO GROUPS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DT) 1978-04-25 US disclosed
US-3962433-A Method of treatment of calcium disorders using phosphonoalkane-polycarboxylic acids HENKEL & CIE G.M.B.H. (DT) 1976-06-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12595209-B2 Mixture comprising glyoxylic acid or condensation or addition products thereof PLOD1, AGXT, ME1 FDPS 4115/4885GABRR1 4423/4885CYP1A2 3834/4885
US-12534405-B2 Shotcrete composition EXOSC10, S100A10, ATXN10 FDPS 4864/4885GABRR1 4752/4885CYP1A2 4634/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.